Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: May 2020

MissionIRNewsBreaks – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Enters Agreement to Acquire Prompt Fission Neutron Equipment and Technology

Posted on May 6, 2020 by MissionIR

Energy Fuels (NYSE American: UUUU) (TSX: EFR), the leading producer of uranium in the United States, today announced its entry into an agreement to acquire from GeoInstruments Logging LLC (“GIL”) all of its Prompt Fission Neutron (“PFN”) technology, equipment and … Continue reading →

Posted in Energy Fuels Inc. UUUU, MissionIRNewsBreaks | Leave a comment

MissionIRNewsBreaks – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Featured in ROTH Equity Research Report

Posted on May 5, 2020 by MissionIR

Energy Fuels (NYSE American: UUUU) (TSX: EFR) was featured in a recent equity research report published by ROTH Capital Partners LLC. The report reads, “On May 1, 2020, UUUU released its financial and operating results for Q1 2020. Based on … Continue reading →

Posted in Energy Fuels Inc. UUUU, MissionIRNewsBreaks | Leave a comment

MissionIRNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Featured in Dougherty & Company LLC Research Report

Posted on May 5, 2020 by MissionIR

Trxade Group Inc. (NASDAQ: MEDS) was featured in a recent equity research report published by Dougherty & Company LLC. The report reads, “We reiterate our Buy rating and $12 Price Target on MEDS following Q1 results that beat expectations. As … Continue reading →

Posted in MissionIRNewsBreaks, Trxade Group Inc. (MEDS) | Leave a comment

MissionIRNewsBreaks – Genprex, Inc. (NASDAQ: GNPX) Expands Oncology Franchise via Exclusive Worldwide Patent and Technology License Agreement

Posted on May 5, 2020 by MissionIR

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, today announced that it has entered into a patent and technology license agreement with The University of Texas MD Anderson Cancer Center, … Continue reading →

Posted in Genprex Inc. GNPX, MissionIRNewsBreaks | Leave a comment

MissionIRNewsBreaks – Pressure BioSciences, Inc. (PBIO) Reveals Plan to Change Company Name to Availa Bio Upon Completion of Cannaworx, SkinScience Transactions

Posted on May 5, 2020 by MissionIR

Pressure BioScience (OTCQB: PBIO) (“PBI”), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics, cosmeceuticals, nutraceuticals, and food & beverage industries, today announced its plan to change … Continue reading →

Posted in MissionIRNewsBreaks, Pressure BioSciences Inc. PBIO | Leave a comment

MissionIRNewsBreaks – Sigma Labs, Inc. (NASDAQ: SGLB) Announces Leadership Changes

Posted on May 4, 2020 by MissionIR

Sigma Labs (NASDAQ: SGLB), a leading developer of quality assurance software for the additive manufacturing industry, today announced its appointment of Mark K. Ruport as president and chief executive officer. According to the update, Ruport will continue to serve as … Continue reading →

Posted in MissionIRNewsBreaks, Sigma Labs Inc. SGLB | Leave a comment

MissionIRNewsBreaks – Youngevity International, Inc.’s (NASDAQ: YGYI) Khrysos Industries Launches Business- and Consumer-Facing Web Interface for FDA-Approved Hand Sanitizers

Posted on May 4, 2020 by MissionIR

Youngevity International (NASDAQ: YGYI), together with its wholly owned subsidiary, Khrysos Industries, Inc., today announced the launch of a web interface dedicated for the sale of the company’s new line of hand sanitizers. The landing page (www.Khrysos-HandSanitizer.com) targets both businesses … Continue reading →

Posted in MissionIRNewsBreaks, Youngevity International Inc. YGYI | Leave a comment

MissionIRNewsBreaks – Genprex, Inc. (NASDAQ: GNPX) Issues Shareholder Letter Highlighting Oncoprex(TM) Progress, License Agreement for a Diabetes Drug Candidate and Other Achievements

Posted on May 4, 2020 by MissionIR

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, today announced its issuance of an April 2020 Shareholder Letter. According to the update, the letter highlights the Company’s progress with Oncoprex(TM), … Continue reading →

Posted in Genprex, Genprex Inc. GNPX, MissionIRNewsBreaks | Leave a comment

MissionIRNewsBreaks – Trxade Group, Inc. (NASDAQ: MEDS) Releases Q1 2020 Financial Results

Posted on May 4, 2020 by MissionIR

Trxade Group, Inc. (NASDAQ: MEDS), an integrated telehealth, drug procurement, delivery and online healthcare marketplace, today reported its financial results for the first quarter ended March 31, 2020. Among the highlights, Trxade reported a 46% increase in Q1 2020 revenues … Continue reading →

Posted in MissionIRNewsBreaks, Trxade Group Inc. (MEDS) | Leave a comment

MissionIRNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Announces Revenue Growth Results, Rebrand of Investor Intelligence Platform, SRAX IR, to Sequire

Posted on May 4, 2020 by MissionIR

SRAX (NASDAQ: SRAX), a digital marketing and consumer data management technology company, today reported results for the year ended December 31, 2019 and the three months ended March 31, 2020. In addition, the company announced the rebrand of its investor … Continue reading →

Posted in MissionIRNewsBreaks, SRAX, Inc. SRAX | Leave a comment